What is CoolStat?
CoolStat, operating under the umbrella of CoolTech Medical, is dedicated to advancing patient care through sophisticated temperature management technology. Their flagship product, CoolStat, employs evaporative cooling to offer a user-friendly, portable, and comfortable solution for regulating patient body temperature. Currently undergoing investigational use, the device is being explored for applications in critical care scenarios such as neurogenic fever and post-cardiac arrest management, positioning CoolStat as a potential leader in non-invasive therapeutic cooling systems for hospital environments.
How much funding has CoolStat raised?
CoolStat has raised a total of $200K across 1 funding round:
Angel/Seed
$200K
Angel/Seed (2022): $200K with participation from Tedco
Key Investors in CoolStat
Tedco
TEDCO, the Maryland Technology Development Corporation, focuses on fostering an inclusive entrepreneurial innovation ecosystem by identifying, investing in, and growing technology and life science-based companies within Maryland.
What's next for CoolStat?
The recent large-scale, late-stage funding indicates CoolStat is poised for significant expansion and market penetration. This capital infusion is likely earmarked for scaling manufacturing, advancing clinical trials, securing regulatory approvals, and broadening market reach. The company's focus on providing a safer, more comfortable alternative to existing cooling methods suggests a strategic push to capture market share in critical care segments, potentially leading to wider adoption across healthcare facilities.
See full CoolStat company page
